Beacon Discovery™ enables real-time functional investigation of single cells. Powered by optofluidic technology, it allows ...

Although the media and the public are worried about the infectious risks of transfusion, hemovigilance reports show that antigen-antibody reactions are responsible for the vast majority of acute ...

COVID-19 testing includes molecular (PCR), antigen (rapid), and antibody (serology) tests, each serving different ...

Groundbreaking study reveals TR1 cells' crucial role in immune response to malaria, paving way for new vaccines and drugs.

The South African Health Products Regulatory Authority (SAHPRA) has announced the approval of the first WHO Emergency Use Listing (EUL) for a test kit for mpox.

Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations ...

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations (autoinjector, prefilled syringe, and single-dose vial) of ...

Clinical trial to evaluate the safety and efficacy of YK012 in primary membranous nephropathy- Globally, this is the first bispecific CD19-directed CD3 T cell engager immunotherapy for this autoimmune ...